BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27558979)

  • 41. PCSK9 R46L, lower LDL, and cardiovascular disease risk in familial hypercholesterolemia: a cross-sectional cohort study.
    Saavedra YG; Dufour R; Davignon J; Baass A
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2700-5. PubMed ID: 25278291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Tracing of patients with familial hypercholesterolemia in the Netherlands].
    Umans-Eckenhausen MA; Defesche JC; Scheerder RL; Cliné F; Kastelein JJ
    Ned Tijdschr Geneeskd; 1999 May; 143(22):1157-61. PubMed ID: 10371839
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial hypercholesterolaemia and quality of life in family members.
    Hollman G; Olsson AG; Ek AC
    Prev Med; 2003 May; 36(5):569-74. PubMed ID: 12689802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cadiovascular complications of homozygous familial hypercholesterolaemia.
    Allen JM; Thompson GR; Myant NB; Steiner R; Oakley CM
    Br Heart J; 1980 Oct; 44(4):361-8. PubMed ID: 7426196
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.
    BMJ; 1991 Oct; 303(6807):893-6. PubMed ID: 1933004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The
    Firus Khan AY; Ramli AS; Abdul Razak S; Mohd Kasim NA; Chua YA; Ul-Saufie AZ; Jalaludin MA; Nawawi H;
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36142062
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TaqIB polymorphism in CETP gene: the influence on incidence of cardiovascular disease in statin-treated patients with familial hypercholesterolemia.
    Mohrschladt MF; van der Sman-de Beer F; Hofman MK; van der Krabben M; Westendorp RG; Smelt AH
    Eur J Hum Genet; 2005 Jul; 13(7):877-82. PubMed ID: 15856070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Type 2 diabetes mellitus in heterozygous familial hypercholesterolaemia: the hazardous intersection of cardiometabolic and genetic risk.
    German CA; Shapiro MD
    Eur J Prev Cardiol; 2022 Jan; 28(16):1817-1818. PubMed ID: 33961017
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term maternal atherosclerotic morbidity in women with pre-eclampsia.
    Kessous R; Shoham-Vardi I; Pariente G; Sergienko R; Sheiner E
    Heart; 2015 Mar; 101(6):442-6. PubMed ID: 25564558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia.
    Koeijvoets KC; van der Net JB; Dallinga-Thie GM; Steyerberg EW; Mensink RP; Kastelein JJ; Sijbrands EJ; Plat J
    Atherosclerosis; 2009 Jun; 204(2):453-8. PubMed ID: 18977479
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Familial hypercholesterolemia: do we know how to diagnose it correctly?].
    Soska V
    Vnitr Lek; 2000 Jan; 46(1):19-23. PubMed ID: 10953659
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The hinterland of familial hypercholesterolaemia: what do we not know?
    Wierzbicki AS; Watts GF
    Curr Opin Lipidol; 2015 Dec; 26(6):475-83. PubMed ID: 26780001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial Hypercholesterolaemia in the Era of Genetic Testing.
    Hughes DP; Viljoen A; Wierzbicki AS
    Curr Cardiol Rep; 2016 May; 18(5):42. PubMed ID: 27002618
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: Levelling up access to treatment urgently needed.
    Stock JK
    Atherosclerosis; 2022 Apr; 346():84-85. PubMed ID: 35246317
    [No Abstract]   [Full Text] [Related]  

  • 56. Lower diabetes rate in patients with familial hypercholesterolaemia: What is the link?
    Parhofer KG
    Eur J Prev Cardiol; 2020 Oct; 27(15):1647-1648. PubMed ID: 32054297
    [No Abstract]   [Full Text] [Related]  

  • 57. Polygenic risk score predicts prevalence of cardiovascular disease in patients with familial hypercholesterolemia.
    Paquette M; Chong M; Thériault S; Dufour R; Paré G; Baass A
    J Clin Lipidol; 2017; 11(3):725-732.e5. PubMed ID: 28456682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Web-Based Registry for Familial Hypercholesterolaemia.
    Napier KR; Pang J; Lamont L; Walker CE; Dawkins HJ; Hunter AA; Bockxmeer FMV; Watts GF; Bellgard MI
    Heart Lung Circ; 2017 Jun; 26(6):635-639. PubMed ID: 28065523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Familial hypercholesterolaemia and primary hypothyroidism: coexistence of both disorders in a young woman with severe hypercholesterolaemia.
    Illingworth DR; McClung MR; Connor WE; Alaupovic P
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):145-52. PubMed ID: 7261412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.